Prescription drug · NDA
Heparin Sodium In Sodium Chloride NDC 0338-0431
heparin sodium · Heparin sodium 200 [USP'U]/100mL · Injection, Solution · Intravenous · Baxter Healthcare Corporation
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 0338-0431-03 | 00338043103 | 18 BAG in 1 CARTON (0338-0431-03) / 500 mL in 1 BAGMarketed from Apr 28, 1982 |
How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Heparin Sodium In Sodium Chloride
- Generic name (nonproprietary)
- heparin sodium
- Active ingredients
- Heparin sodium — 200 [USP'U]/100mL
- Dosage form
- Injection, Solution
- Route
- Intravenous
- Product type
- Prescription drug
- Marketing category
- NDA — New Drug ApplicationApplication NDA 018609
- Marketing start
- Listing expires
- Other FDA classes
- Heparin (Chemical structure)
- Identifiers
- Product ID 0338-0431_d28ff87a-c535-49db-ba0c-48080149936bSPL ID d28ff87a-c535-49db-ba0c-48080149936bSPL set ID 0d929726-76c3-48fc-b4e7-fd06409f9fb3RxCUI 1658690, 1658692UNII ZZ45AB24CA
- Pharmacologic class
- Anti-coagulant; Unfractionated Heparin
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.
- Administration
Drug administration (CPT 96360–96549)
When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.
- NDC on a medical claim
N400338043103followed by a unit qualifier and the quantityPackage 00338-0431-03. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
Heparin Sodium in Sodium Chloride Injection at a concentration of 2 units/mL is indicated as an anticoagulant to maintain catheter patency. Heparin Sodium in Sodium Chloride Injection at a concentration of 2 units/mL is indicated as an anticoagulant to maintain catheter patency. ( 1 )
Excerpt only. Read the full label for complete information.
Other NDCs under NDA 018609
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Heparin Sodium In Sodium Chlorideheparin sodium | Heparin sodium 200 [USP'U]/100mL | Injection, SolutionIntravenous | Baxter Healthcare Corporation | 0338-0424 |
| Heparin Sodium In Sodium Chlorideheparin sodium | Heparin sodium 200 [USP'U]/100mL | Injection, SolutionIntravenous | Baxter Healthcare Corporation | 0338-0428 |
| Heparin Sodium In Sodium Chlorideheparin sodium | Heparin sodium 200 [USP'U]/100mL | Injection, SolutionIntravenous | Baxter Healthcare Corporation | 0338-0433 |